Stay updated with breaking news from Enforcement Report. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Newsroom is open 24 hours, please reach us by email at info@canyon-news.com or by phone Monday through Friday 9-5. You can place DBA (Fictitious Business Name Statement) orders online by clicking on the link Legal Filings
ICRA assigns A1+ rating to Vedanta's commercial paper, JioFinance launches super-app, Orient Electric appoints new MD, Sun Pharma recalls products.
Aurobindo Pharma | The company had reported 80 percent rise in consolidated net profit to Rs 909 crore in the Jan-March quarter of FY24 from Rs 508 crore in the same period a year ago.
Drug maker Aurobindo Pharma on Saturday announced that the US Food and Drug Administration (FDA) has classified Eugia Pharma Specialities' (a wholly owned subsidiary of the company) formulation manufacturing facility -- Unit III, as 'Official ...
New Delhi, May 25 (IANS) Drug maker Aurobindo Pharma on Saturday announced that the US Food and Drug Administration (FDA) has classified Eugia Pharma